NAT10 and breast cancer: To dissect the functions of NAT10 in breast cancer, we generated two independent NAT10 inducible knockdown 231-BrM3 cell lines (Fig. 2A) and demonstrated that knockdown of NAT10 significantly decreased the clonogenic ability of 231-BrM3 (Fig. 2, B and C).